{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:16:56Z","timestamp":1773209816205,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000728","name":"Trinity College, University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.yebeh.2021.108191","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T19:36:46Z","timestamp":1626118606000},"page":"108191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The relationship between antiepileptic drug load and challenging behaviors in older adults with intellectual disability and epilepsy"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2758-8575","authenticated-orcid":false,"given":"Rosemary","family":"Monaghan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1ire","family":"O'Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Retha","family":"Luus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niamh","family":"Mulryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"McCallion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"McCarron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin C.","family":"Henman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2021.108191_b0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yebeh.2013.11.010","article-title":"Disentangling the relationship between epilepsy and its behavioral comorbidities - the need for prospective studies in new-onset epilepsies","volume":"31","author":"Helmstaedter","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108191_b0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yebeh.2016.04.018","article-title":"A systematic review of neuropsychiatric comorbidities in patients with both epilepsy and intellectual disability","volume":"60","author":"van Ool","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108191_b0015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ridd.2018.05.007","article-title":"Prevalence and associated factors of problem behaviours among older adults with intellectual disabilities in Ireland","volume":"80","author":"O\u2019Dwyer","year":"2018","journal-title":"Res Dev Disabil"},{"key":"10.1016\/j.yebeh.2021.108191_b0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2788.2006.00948.x","article-title":"Challenging behaviours: prevalence and topographies","volume":"51","author":"Lowe","year":"2007","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.yebeh.2021.108191_b0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/13668250.2017.1327039","article-title":"Epilepsy and challenging behaviour in adults with intellectual disability: A systematic review","volume":"44","author":"Blickwedel","year":"2019","journal-title":"J Intellect Dev Disabil"},{"key":"10.1016\/j.yebeh.2021.108191_b0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1192\/apt.bp.113.011577","article-title":"Interventions for challenging behaviour in intellectual disability","volume":"20","author":"Ali","year":"2014","journal-title":"Adv Psychiatr Treat"},{"key":"10.1016\/j.yebeh.2021.108191_b0035","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.ridd.2010.04.003","article-title":"Behavior problems: differences among intellectually disabled adults with co-morbid autism spectrum disorders and epilepsy","volume":"31","author":"Smith","year":"2010","journal-title":"Res Dev Disabil"},{"key":"10.1016\/j.yebeh.2021.108191_b0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-2788.2003.00517.x","article-title":"Risk markers associated with challenging behaviours in people with intellectual disabilities: a meta-analytic study","volume":"47","author":"McClintock","year":"2003","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.yebeh.2021.108191_b0045","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2020.96","article-title":"Association between epilepsy and challenging behaviour in adults with intellectual disabilities: systematic review and meta-analysis","volume":"6","author":"Deb","year":"2020","journal-title":"BJPsych Open"},{"key":"10.1016\/j.yebeh.2021.108191_b0050","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2788.2011.01390.x","article-title":"Physical conditions and challenging behaviour in people with intellectual disability: a systematic review","volume":"55","author":"de Winter","year":"2011","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.yebeh.2021.108191_b0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1528-1167.2006.00684.x","article-title":"Effects of antiepileptic drugs on mood and behavior","volume":"47","author":"Schmitz","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108191_b0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/epi4.12018","article-title":"Behavioral disorder in people with an intellectual disability and epilepsy: A report of the Intellectual Disability Task Force of the Neuropsychiatric Commission of ILAE","volume":"1","author":"Kerr","year":"2016","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2021.108191_b0065","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.yebeh.2012.09.018","article-title":"Antiepileptic drug effects on mood and behavior: molecular targets","volume":"26","author":"Perucca","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108191_b0070","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2165\/00002018-200730070-00001","article-title":"Negative effects of antiepileptic drugs on mood in patients with epilepsy","volume":"30","author":"Mula","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.yebeh.2021.108191_b0075","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.ridd.2011.06.007","article-title":"Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability","volume":"32","author":"Leunissen","year":"2011","journal-title":"Res Dev Disabil"},{"key":"10.1016\/j.yebeh.2021.108191_b0080","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1535-7511.2005.00056.x","article-title":"Psychotropic effects of antiepileptic drugs","volume":"5","author":"Nadkarni","year":"2005","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2021.108191_b0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1528-1157.1998.tb01373.x","article-title":"Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine","volume":"39","author":"Beran","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108191_b0090","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1525-5050(03)00005-2","article-title":"A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials","volume":"4","author":"Cramer","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108191_b0095","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0009-9236(97)90078-3","article-title":"Drug load in clinical trials: a neglected factor","volume":"62","author":"Deckers","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.yebeh.2021.108191_b0100","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1528-1157.1997.tb01142.x","article-title":"Reappraisal of polytherapy in epilepsy: a critical review of drug load and adverse effects","volume":"38","author":"Deckers","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108191_b0105","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.yebeh.2018.09.010","article-title":"Treatment of psychiatric comorbidities in patients with epilepsy and intellectual disabilities: Is there a role for the neurologist?","volume":"98","author":"Watkins","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108191_b0110","doi-asserted-by":"crossref","unstructured":"Kerr MP, Mensah S, Besag F, de Toffol B, Ettinger A, Kanemoto K, et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011;52: 2133-8.","DOI":"10.1111\/j.1528-1167.2011.03276.x"},{"key":"10.1016\/j.yebeh.2021.108191_b0115","doi-asserted-by":"crossref","unstructured":"Kerr M, Scheepers M, Arvio M, Beavis J, Brandt C, Brown S, et al. Consensus guidelines into the management of epilepsy in adults with an intellectual disability. J Intellect Disabil Res 2009;53: 687-94.","DOI":"10.1111\/j.1365-2788.2009.01182.x"},{"key":"10.1016\/j.yebeh.2021.108191_b0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1352\/1944-7558-119.3.253","article-title":"Epidemiology of epilepsy in older adults with an intellectual disability in Ireland: associations and service implications","volume":"119","author":"McCarron","year":"2014","journal-title":"Am J Intellect Dev Disabil"},{"key":"10.1016\/j.yebeh.2021.108191_b0125","series-title":"Growing older with an intellectual disability in Ireland 2011: First results from the intellectual disability supplement to the Irish Longitudinal Study on Ageing","author":"McCarron","year":"2011"},{"key":"10.1016\/j.yebeh.2021.108191_b0130","series-title":"The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions and diagnostic guidelines","author":"WHO","year":"1992"},{"key":"10.1016\/j.yebeh.2021.108191_b0135","unstructured":"IDS-TILDA.Health, wellbeing, and social inclusion: ageing with an intellectual disability in Ireland. Evidence from the first ten years of the Intellectual Disability Supplement to the Irish Longitudinal Study on Ageing (IDS-TILDA). Trinity College Dublin. 2017, Available from https:\/\/www.tcd.ie\/tcaid\/assets\/pdf\/wave3report.pdf."},{"key":"10.1016\/j.yebeh.2021.108191_b0140","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"12","author":"Vandenbroucke","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.yebeh.2021.108191_b0145","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/jar.12857","article-title":"Antiepileptic drugs, occurrence of seizures and effect of co-administration of potential seizure threshold-lowering psychotropic drugs in adults with intellectual disability who have epilepsy","volume":"34","author":"Monaghan","year":"2021","journal-title":"J Appl Res Intellect Disabil"},{"key":"10.1016\/j.yebeh.2021.108191_b0150","doi-asserted-by":"crossref","first-page":"e010505","DOI":"10.1136\/bmjopen-2015-010505","article-title":"Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study","volume":"6","author":"O'Dwyer","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.yebeh.2021.108191_b0155","unstructured":"SmPC (Midazolam). Buccolam (Midazolam) UK and Ireland. Shire, Available from https:\/\/www.medicines.ie\/medicines\/buccolam-2-5mg-5mg-7-5mg-and-10mg-oromucosal-solution-31492\/smpc, Accessed 22nd August 2019."},{"key":"10.1016\/j.yebeh.2021.108191_b0160","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1046\/j.1528-1157.2001.30800.x","article-title":"Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study","volume":"42","author":"Deckers","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108191_b0165","doi-asserted-by":"crossref","unstructured":"Rojahn J, Rowe EW, Sharber AC, Hastings R, Matson JL, Didden R, Kroes DBH, Dumont ELM. The Behavior Problems Inventory-Short Form for individuals with intellectual disabilities: Part I: development and provisional clinical reference data. J Intellect Disabil Res 2012;56: 527-545.","DOI":"10.1111\/j.1365-2788.2011.01507.x"},{"key":"10.1016\/j.yebeh.2021.108191_b0170","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jar.12152","article-title":"The Behaviour Problems Inventory-Short Form: reliability and factorial validity in adults with intellectual disabilities","volume":"28","author":"Mascitelli","year":"2015","journal-title":"J Appl Res Intellect Disabil"},{"key":"10.1016\/j.yebeh.2021.108191_b0175","unstructured":"International League Against Epilepsy (ILAE). Classification of the Epilepsies. 2017, Available from https:\/\/www.ilae.org\/guidelines\/definition-and-classification\/ilae-classification-of-the-epilepsies-2017, Accessed 20th September 2020."},{"key":"10.1016\/j.yebeh.2021.108191_b0180","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.yebeh.2021.108191_b0185","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.yebeh.2021.108191_b0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1525-5050(02)00537-1","article-title":"Behavioral assessment in mentally retarded and developmentally disabled patients with epilepsy","volume":"3","author":"Kerr","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108191_b0195","doi-asserted-by":"crossref","unstructured":"Working group of the International Association of the Scientific Study of Intellectual Disability. Clinical guidelines for the management of epilepsy in adults with an intellectual disability. Seizure 2001;10: 401-409.","DOI":"10.1053\/seiz.2001.0528"},{"issue":"Suppl 4","key":"10.1016\/j.yebeh.2021.108191_b0200","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.yebeh.2003.10.002","article-title":"Psychiatric comorbidity in patients with epilepsy: implications for diagnosis and treatment","volume":"4","author":"Devinsky","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108191_b0205","doi-asserted-by":"crossref","first-page":"s65","DOI":"10.1111\/j.1528-1157.1999.tb00887.x","article-title":"Psychiatric syndromes related to antiepileptic drugs","volume":"40","author":"Schmitz","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108191_b0210","doi-asserted-by":"crossref","unstructured":"Espie CA, Gillies JB, Montgomery JM. Antiepileptic polypharmacy, psychosocial behaviour and locus of control orientation among mentally handicapped adults living in the community. J Intellect Disabil Res 1990;34: 351-360.","DOI":"10.1111\/j.1365-2788.1990.tb01545.x"},{"key":"10.1016\/j.yebeh.2021.108191_b0215","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0920-1211(90)90079-B","article-title":"Epilepsy in a population of mentally retarded children and adults","volume":"6","author":"Forsgren","year":"1990","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2021.108191_b0220","doi-asserted-by":"crossref","unstructured":"Canevini MP, De Sarro G, Galimberti CA, Gatti G, Licchetta L, Malerba A, Muscas G, La Neve A, Striano P, Perucca E, Group SS. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia 2010;51: 797-804.","DOI":"10.1111\/j.1528-1167.2010.02520.x"},{"key":"10.1016\/j.yebeh.2021.108191_b0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0920-1211(02)00180-8","article-title":"Pharmacological overtreatment in epilepsy: mechanisms and management","volume":"52","author":"Schmidt","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2021.108191_b0230","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2788.2007.00965.x","article-title":"The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: a systematic review","volume":"52","author":"Deb","year":"2008","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.yebeh.2021.108191_b0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jir.12273","article-title":"An exploration of the bone health of older adults with an intellectual disability in Ireland","volume":"61","author":"Burke","year":"2017","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.yebeh.2021.108191_b0240","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bone.2014.04.018","article-title":"Association between use of antiepileptic drugs and fracture risk: a systematic review and meta-analysis","volume":"64","author":"Shen","year":"2014","journal-title":"Bone"},{"issue":"Suppl 8","key":"10.1016\/j.yebeh.2021.108191_b0245","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1528-1157.42.s8.8.x","article-title":"Cognitive and behavioral effects of epilepsy treatment","volume":"42","author":"Loring","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108191_b0250","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/jnnp.74.11.1485","article-title":"Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables","volume":"74","author":"Espie","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2021.108191_b0255","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/JCP.0b013e318253a186","article-title":"Behavioral adverse effects of antiepileptic drugs in epilepsy","volume":"32","author":"Eddy","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.yebeh.2021.108191_b0260","doi-asserted-by":"crossref","unstructured":"Espie CA, Pashley AS, Bonham KG, Sourindhrin I, O'Donovan M. The mentally handicapped person with epilepsy: a comparative study investigating psychosocial functioning. J Intellect Disabil Res 1989;33: 123-135.","DOI":"10.1111\/j.1365-2788.1989.tb01459.x"},{"key":"10.1016\/j.yebeh.2021.108191_b0265","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.yebeh.2003.07.007","article-title":"A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events","volume":"4","author":"Kanner","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108191_b0270","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1111\/j.1528-1157.1995.tb05999.x","article-title":"Cognitive and behavioral effects of antiepileptic drugs","volume":"36","author":"Devinsky","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108191_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1684\/epd.2009.0238","article-title":"Antiepileptic drugs and psychopathology of epilepsy: an update","volume":"11","author":"Mula","year":"2009","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2021.108191_b0280","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/ene.13016","article-title":"Managing anti-epileptic drug treatment in adult patients with intellectual disability: a serious conundrum","volume":"23","author":"Doran","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2021.108191_b0285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/14656566.2019.1695780","article-title":"Quality improvement in the management of people with epilepsy and intellectual disability: the development of clinical guidance","volume":"21","author":"Watkins","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.yebeh.2021.108191_b0290","article-title":"Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study","volume":"351","author":"Sheehan","year":"2015","journal-title":"BMJ"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021004522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021004522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:43:28Z","timestamp":1761504208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505021004522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":58,"alternative-id":["S1525505021004522"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108191","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between antiepileptic drug load and challenging behaviors in older adults with intellectual disability and epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108191"}}